145 related articles for article (PubMed ID: 28785576)
1. Anti-Parkinson Drug Biperiden Inhibits Enzyme Acetylcholinesterase.
Kostelnik A; Cegan A; Pohanka M
Biomed Res Int; 2017; 2017():2532764. PubMed ID: 28785576
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib is an inhibitor of enzyme acetylcholinesterase.
Pohanka M
Neuro Endocrinol Lett; 2016 Dec; 37(Suppl1):118-122. PubMed ID: 28263539
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015).
McHardy SF; Wang HL; McCowen SV; Valdez MC
Expert Opin Ther Pat; 2017 Apr; 27(4):455-476. PubMed ID: 27967267
[TBL] [Abstract][Full Text] [Related]
4. In-silico and in-vitro evaluation of human acetylcholinesterase inhibition by organophosphates.
Ranjan A; Chauhan A; Jindal T
Environ Toxicol Pharmacol; 2018 Jan; 57():131-140. PubMed ID: 29272792
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 2,6-dichlorophenolindophenol acetate as a substrate for acetylcholinesterase activity assay.
Pohanka M; Holas O
J Enzyme Inhib Med Chem; 2015; 30(5):796-9. PubMed ID: 25672529
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-acetylcholinesterase activity of scopoletin derivatives.
Khunnawutmanotham N; Chimnoi N; Saparpakorn P; Techasakul S
Bioorg Chem; 2016 Apr; 65():137-45. PubMed ID: 26943478
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of vincamine against Acetylcholinesterase enzyme.
Syed Sayeed Ahmad ; Khatoon A; Sajid Khan M; Khalid M; Alharbi AM; Siddiqui MH
Cell Mol Biol (Noisy-le-grand); 2022 Jul; 68(7):14-21. PubMed ID: 36495525
[TBL] [Abstract][Full Text] [Related]
8. Studying enzyme binding specificity in acetylcholinesterase using a combined molecular dynamics and multiple docking approach.
Kua J; Zhang Y; McCammon JA
J Am Chem Soc; 2002 Jul; 124(28):8260-7. PubMed ID: 12105904
[TBL] [Abstract][Full Text] [Related]
9. Probing the acetylcholinesterase inhibition of sarin: a comparative interaction study of the inhibitor and acetylcholine with a model enzyme cavity.
Majumdar D; Roszak S; Leszczynski J
J Phys Chem B; 2006 Jul; 110(27):13597-607. PubMed ID: 16821887
[TBL] [Abstract][Full Text] [Related]
10. Combining in silico and in vitro approaches to evaluate the acetylcholinesterase inhibitory profile of some commercially available flavonoids in the management of Alzheimer's disease.
Kuppusamy A; Arumugam M; George S
Int J Biol Macromol; 2017 Feb; 95():199-203. PubMed ID: 27871793
[TBL] [Abstract][Full Text] [Related]
11. Myrtenal inhibits acetylcholinesterase, a known Alzheimer target.
Kaufmann D; Dogra AK; Wink M
J Pharm Pharmacol; 2011 Oct; 63(10):1368-71. PubMed ID: 21899553
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of some N-methylenebenzenamine derivatives as selective acetylcholinesterase (AChE) inhibitor and antioxidant to enhance learning and memory.
Shrivastava SK; Srivastava P; Upendra TVR; Tripathi PN; Sinha SK
Bioorg Med Chem; 2017 Feb; 25(4):1471-1480. PubMed ID: 28126439
[TBL] [Abstract][Full Text] [Related]
13. Effect of isoquinoline alkaloids from two Hippeastrum species on in vitro acetylcholinesterase activity.
Pagliosa LB; Monteiro SC; Silva KB; de Andrade JP; Dutilh J; Bastida J; Cammarota M; Zuanazzi JA
Phytomedicine; 2010 Jul; 17(8-9):698-701. PubMed ID: 19969445
[TBL] [Abstract][Full Text] [Related]
14. A mechanism-based 3D-QSAR approach for classification and prediction of acetylcholinesterase inhibitory potency of organophosphate and carbamate analogs.
Lee S; Barron MG
J Comput Aided Mol Des; 2016 Apr; 30(4):347-63. PubMed ID: 27055524
[TBL] [Abstract][Full Text] [Related]
15. Amino derivatives of glycyrrhetinic acid as potential inhibitors of cholinesterases.
Schwarz S; Lucas SD; Sommerwerk S; Csuk R
Bioorg Med Chem; 2014 Jul; 22(13):3370-8. PubMed ID: 24853320
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of novel 1,2-oxazine-based small molecules that targets acetylcholinesterase.
Sukhorukov AY; Nirvanappa AC; Swamy J; Ioffe SL; Nanjunda Swamy S; Basappa ; Rangappa KS
Bioorg Med Chem Lett; 2014 Aug; 24(15):3618-21. PubMed ID: 24909082
[TBL] [Abstract][Full Text] [Related]
17. Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition.
Khan NA; Khan I; Abid SMA; Zaib S; Ibrar A; Andleeb H; Hameed S; Iqbal J
Med Chem; 2018; 14(1):74-85. PubMed ID: 28545383
[TBL] [Abstract][Full Text] [Related]
18. Ibogaine and the inhibition of acetylcholinesterase.
Alper K; Reith ME; Sershen H
J Ethnopharmacol; 2012 Feb; 139(3):879-82. PubMed ID: 22200647
[TBL] [Abstract][Full Text] [Related]
19. Efficient synthesis of novel dialkyl-3-cyanopropylphosphate derivatives and evaluation of their anticholinesterase activity.
Aouani I; Sellami B; Lahbib K; Cavalier JF; Touil S
Bioorg Chem; 2017 Jun; 72():301-307. PubMed ID: 28500956
[TBL] [Abstract][Full Text] [Related]
20. The characterization of Lucilia cuprina acetylcholinesterase as a drug target, and the identification of novel inhibitors by high throughput screening.
Ilg T; Cramer J; Lutz J; Noack S; Schmitt H; Williams H; Newton T
Insect Biochem Mol Biol; 2011 Jul; 41(7):470-83. PubMed ID: 21530657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
